By using different bases, a conjugated acrylonitrile with mixed intramolecular TBCT plus intermolecular TSCT emission and an oxirane-based non-conjugated dye with pure intermolecular TSCT emission in aggregate and crystalline states were realized.
Deep-red (DR) and near-infrared (NIR) luminogens have
witnessed
powerful applications in various aspects in recent decades. However,
their inevitably complicated structures not only bring tedious and
time-consuming synthesis, but also lead to inherent difficult in crystallization
which hinder the understanding of structure-emission relationship.
Polymorphism represents an ingenious strategy for revealing unambiguous
structure-emission relationships. Therefore, designing simple molecules
to construct DR and NIR polymorphic emission is challenging yet highly
desirable. Herein, multiple DR and NIR emission ranges from 624 to
742 nm is achieved in polymorphisms of an extremely simple π-conjugated
luminogen. Multiple packing modes are simultaneously integrated into
this compound. Its unique packing-dependent emission facilitates the
establishment of clear packing-emission relationship. Increased intermolecular
exciton coupling between adjacent molecules leads to gradually red-shifted
emission from orange to DR and finally to NIR. The aggregation-induced
emission feature of the molecule renders the bulk crystals with visible
crystal-to-crystal polymorphic transformation under external stimuli.
This work not only breaks the limitations of the research of organic
polymorphism materials with NIR emission, but also provides a reliable
strategy to reveal the influence of molecular packing on NIR emission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.